Actively Recruiting
Ameliorative Potential of Electroacupoint for Diminutive Milk Production in Lactating Women
Led by Haytham Ibrahim Morsi · Updated on 2024-09-19
36
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the effect of electroacupoint stimulation on scanty milk production in lactating women aged 25 to 30 years who have experienced insufficient milk supply after cesarean section. The study aims to find safe and effective ways to increase milk production without causing adverse effects to mother or child, addressing common concerns linked to medications like domperidone which may cause side effects such as dry mouth and headache. Participants are randomly assigned to one of two groups: one receives electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit combined with a balanced postnatal care diet including domperidone, iron, and folic acid supplements; the other group receives the postnatal care diet alone. Electroacupoint stimulation is a noninvasive, needleless procedure targeting acupuncture points to influence energy flow and promote balance. During the three-month study period, researchers will monitor changes in baby weight, serum prolactin levels, and milk flow from baseline measurements. Participants' adherence to the intervention and postnatal care will be tracked, and safety will be observed. The study will evaluate whether electroacupoint stimulation combined with nutritional support can improve lactation outcomes compared to diet alone.
CONDITIONS
Brief Title
Electroacupoint for Diminutive Milk Production
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Complaints of insufficient lactation within the first month after cesarean section
- Using mixed feeding with both breast and bottle feeding between three and six bottles per day
- Age between 25 and 30 years
- Body mass index (BMI) not exceeding 30 kg/m2
You will not qualify if you...
- Postpartum haemorrhage
- Cardiorespiratory disease
- Diabetes mellitus
- Breast cancer
- Previous surgeries in the chest, breast, or surrounding area
- Anemia
- Any condition hindering normal breastfeeding such as retracted, cracked, inflamed, or inverted nipples
- Receiving contraceptive pills
- Infants with conditions affecting lactation such as congenital mouth abnormalities (tongue tie, cleft palate)
- Congenital heart disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants receive either electroacupoint stimulation combined with postnatal care diet or postnatal care diet only to improve milk production after cesarean section.
Regular visits during the treatment period
Trial Site Locations
Total: 1 location
1
Kafrelsheikh University
Kafrelsheikh, Egypt
Actively Recruiting
Research Team
S
Sara E Seyam, B.Sc.
H
Haytham I Morsi, M.Sc.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here